In addition, individuals with PWS have increased ghrelin levels with lower insulin and peptide YY (PYY) levels with associated leptin and insulin resistance at the blood-brain barrier, which decreases the hormones that promote satiety at the level of the hypothalamus [1,3]. The gene discussed is INS; the disease is Prader-Willi syndrome.